Company Overview
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Company Information
- CEO
- Kevin A. Lobo
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 53000
Contact Information
- Website
- https://www.stryker.com
- Address
- 2825 Airview Boulevard
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 144.83B market capitalization
- Trading Volume: 78.42K shares traded today
- Price Range: 52-week range of $322.03 - $406.19
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Stryker Corporation
Stryker Corporation (SYK) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 144.83B, the company represents a significant player in its market. The stock is currently trading at $378.84 with a positivedaily change of 0.66%.
The company's 53000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 50.24, beta of 0.91, and 52-week price range from $322.03 to $406.19when evaluating investment opportunities.
Why Invest in Stryker Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Kevin A. Lobo
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.